Smary A small, fast-growing and non-differentiated clone (N.1) derived from the heterogeneous human epithelial ovarian carcinoma cell line HOC-7 produces an autocrine/paracrine factor that is secreted into the cell culture supernatant. This factor is capable of enhancing mRNA levels of the proliferation-related oncogene c-myc in the more differentiated clone D3 and in normal human fibroblasts MRC.5, but also in N.1 cells themselves. Supernatants enriched for this paracrine/autocrine factor also confer a mitogenic stimulus as measured by [3HJthymidine incorporation. Trypsin can neutralise the stimulating activity of the secreted factor as well as monoclonal antibodies directed against macrophage colony-stimulating factor (M-CSF). We show that M-CSF and also M-CSF receptor are expressed in N.1 cells and that recombinant M-CSF induces c-myc transcript levels in N.1 cells. This investigation raises the possibility that M-CSF might be an autocrine growth factor in non-differentiated ovarian carcinomas. Inappropriate cytokine production could create a tumourpromoting microenvironment in this cancer type.
Ovarian cancer is responsible for the most fatalities among all gynaecological malignancies, however compared with other tumour types little is known about epithelial ovarian carcinomas. Elucidation of the basic biology of this tumour might be helpful for the development of more efficient therapeutic strategies.
In order to gain a better understanding of this disease, the HOC-7 polyclonal human epithelial ovarian adenocarcinoma cell line, derived from a highly malignant ovarian cancer (Filmus and Buick, 1985) , was characterised . Recently homogeneous sublines were isolated (Grunt et al., 1991a) , two of which are the subject of ongoing investigations. Subline N.l resembles the small morphology and the fast-growing phenotype of parental HOC-7 cells, whereas subline D.3 exhibits slow growth and appears to differentiate spontaneously, expressing a variety of genes correlated with an advanced stage of differentiation (Somay et al., 1992; Grunt et al., 1993a) .
As shown previously, the differentiation inducers dimethylsulphoxide (DMSO), dimethylformamide (DMF), transforming growth factor P (TGF-P) and all-trans retinoic acid (ATRA) can differentiate both the HOC-7 cell line and its subclone N.1 into a phenotype comparable to that of the spontaneously differentiated subline D.3 in terms of proliferation rate, cell morphology and protein expression (Grunt et al., 1991b (Grunt et al., , 1992a (Grunt et al., ,b, 1993b .
During the characterisation of the HOC-7 sublines, it was found that N.1 secretes a factor into the culture supernatant (supe) that autocrinely up-regulates, among others (e.g. plasminogen activator-urokinase, pradl oncogene, unpublished observations) c-myc mRNA transcripts. Subsequently, DNA synthesis is induced, thus the autocrine factor is conferring a mitogenic stimulus. It was found that the parental cell line HOC-7 produces cytokines typical of monocyte-macrophage lineages, such as constitutively expressed interleukin 6 and interleukin 1 and interleukin 8 upon stimulation with ATRA (unpublished observations). In this investigation the autocrne activity will be restricted to a limited number of possible factors. [3H]thymidine (1 LCi gl l'; 5-10 Ci mmol-l; Dupont-NEN, Wilmington, DE, USA) was kindly donated by Ernst Mfillner, VBC, Vienna, Austria.
Human recombinant macrophage colony-stimulating factor (M-CSF) was purchased from Genzyme (Cambridge, MA, USA), monoclonal anti-M-CSF rat IgG from Oncogene Science (Manhasset, NY, USA), aprotinin from Bohringer (Mannheim, Germany) and trypsin (cell culture grade) from Gibco (Paisley, UK). Phorbol 12-myristate 13-acetate (TPA) was purchased from Sigma (St Louis, MO, USA), casein kinase I inhibitor CKL-7 and protein kinase A (PKA) inhibitor H-89 from Seikagaku (Tokyo, Japan) and genistein from Upstate Biotechnology (Lake Placid, NY, USA).
Cell culture
Normal human lung fibroblasts MRC.5 (ATCC) and the human ovarian adenocarcinoma sublines N.l and D.3 (Somay et al., 1992; Grunt et al., 1993a) , which were isolated from the HOC-7 heterogenous cell line Grunt et al., 199 la), were kept in alpha-minimum essential medium (MEM) (Gibco) and the human leukaemia cell line HL-60 in RPMI-1640 (Gibco), all of which were supplemented with 10% heat-inactivated fetal calf serum (FCS, Gibco) Conditioned supernatants which contained 10% FCS (used routinely) and which were capable of inducing oncogene transcription were derived from cells that just reached confluence or had already been confluent for 1 or 2 days. They were cleared of any possible debris by short centrifugation, aliquoted and stored at -80C.
[3H]thymidine incorporation D.3 control and N. 1-inducing supernatants (supematants of both cell lines were conditioned for 11 days in the absence of FCS after reaching confluence) were applied onto 50-60% confluent N.1 cell cultures and the cells exposed for 4, 6, 8, 18 and 26 h. [3H]thymidine (2 #Ci ml-') was added to each culture well (0.5 ml of medium) for a pulse label of 2 h. Subsequently, the supernatants were discarded, the cells rinsed once with ice-cold alpha-MEM and twice with ice-cold PBS, followed by cell lysis using 0.5% SDS, 20 mm EDTA. Lysates were ethanol precipitated and DNA measured by spectrophotometry (A" readings). The same amounts of [3Hjthymidine-labelled DNA samples were analysed by scitillation counting.
Northern blot analysis Induction of transcription: Conditioned supernatants were applied onto 80% confluent N.1 cell cultures. Supernatants derived from 80% confluent cells served as negative controls. The treatment times are given in the figure leends. Experiments were terminated by discarding the conditioned culture medium and quickly rinsing the monolayers twice with ice-cold PBS and subsequently lysing cells by the addition of 1 ml of RNAzol (BioTex, Houston, TX, USA).
All solutions and buffers coming into contact with RNA were steilised. Thirty micrograms of total RNA per slot was separated using formaldehyde-contig agarose gels at 4-C (80 V constant voltage). Gels were soaked in 50 mM sodium hydroxide, 100 mM sodium chloride for 30 mi, equilibrated for 30 min in 100 mM Tris pH 7.5 and subsequenty for 30min in 2 x SSC ( x SSC= 150mM sodium chloride, 15 mM sodium citrate, pH 7.0). Separated RNA was transferred to Immobilon S membranes (Millipore, Bedford, MA, USA) by the capillary method using 10 x SSC as the transporting phase. Filters were prehybridised in a buffer containing 7% SDS, 1% BSA, 0.5% pyrophosphate, 10mg ml-' salmon sperm DNA and 500 mM sodium phosphate pH 7.2 for 2h. This buffer enhances sensitivity 5-to 10-fold by limiting high backgrounds. Biotinylated probes were added at a concentration of 20 ng ml-' to the buffer used for prehybridisation (GAPDH only at a concentration of 3 ngml-1), and allowed to hybridise to the filter-bound RNA at 6TC overnight. Filters were further processed according to the instructions given by the manufacturer (PolarPlex detection kit, Millipore). Blocking and washing steps were extended severalfold. Processed filters were exposed for 10-90 min to Kodak X-ray films (Rochester, NY, USA).
Biotinylation of DNA probes using the PolarPlex labelling kit (Millipore) was done by a modified procedure. Random primers and cDNA probes were boiled together for 5 mi, then quickly chilled on ice, dNTPs and Kkenow fragment added and the synthesis reaction allowed to continue for 6 h at 15'C.
This procedure resulted in labelled fragments which were similar in size to unlabelled cDNA probes and exhibited improved sensitivity and specificity.
Reverse transcnption-polymerase chai reaction (RT-PCR)
Total RNA from N.1 cells was extracted using RNAzol sion in subconfluent N. 1 cells, whereas the same medium failed to stimulate mRNA levels in confluent N.1 cells, from which the inducing supernatants had been derived (compare Figure 3 with Figure 1 ), reveals a new aspect of c-myc transregulation and has to be followed in an independent set of experiments.
The N. 1-secreted activity stimulates DNA synthesis Incorporation of radiolabelled thymidine into replicating DNA is a very sensitive method of studying mitogenic The DNA content for each reaction was determined and incorporated activity was standardised to the same amounts of DNA. Maximal induction (10-fold above the control level) elicited by N.1 conditioned supernatant occurred 6h after application, i.e. 2-3 h before peak of c-myc mRNA accumulation. The thymidine incorporation data clearly demonstrate that stimulation by the secreted factor only allows for one single round of cell division, otherwise the effect would not decline to control levels within 26h. We have previously shown that N.1 cells have a doubling time of 24 h (Somay et al., 1992) . These data indicate a functional relation between c-myc transcriptional induction by autocrine factors and cell proliferation of the N.1 ovarian carcinoma subline.
The autocrine factor is susceptible to protease inactivation Preincubating conditioned supernatants with trypsin (10ILgml]') for 2h resulted in complete inhibition of the c-myc-inducing activity ( Figure 5, lane 3) . Inhibition of trypsin itself by aprotinin (50 ;g ml-') restored the effect ( Figure  5 , lane 4). Aprotinin was added to both the positive and negative controls to exclude non-specific aprotinin-mediated interactions ( Figure 5, lanes 1 and 2) . Thus the c-mycinducing factor is apparently a protein. Figure   7a ). Genistein (50 iM final concentration) completely inhibited constitutive c-myc expression and also autocrine factor-induced stimulation. On the other hand, inhibition of protein kinase A (PKA) by H-89 (500 nM final concentration) generally increased c-myc expression but had no separate effect on factor-induced c-myc transcript levels. Ckl-7 (10 mM final concentration), an inhibitor of casein kinase I, abolished the inducibility of autocrine factor-mediated c-myc stimulation (Figure 7b ).
Dicssiom
The fast growing subclone N. 1 maintains unchanged levels of constitutive c-myc transcripts, whereas subclone D.3, which is slow-growing, down-regulates c-myc mRNA levels after reaching confluence. Constitutive c-myc expression as is observed in N.1 cells is typical of highly transformed, continuously proliferating cancer cells (Hann et al., 1985; Edelman et al., 1987) and has been shown to be a major factor inhibiting the differentiation processes (Resnitzky et al., 1986; Spotts and Hann, 1990) .
In Little is known about ovarian autocrine biochemisty, however some autocrine and paracrine factors generated by ovarian cancers have been described. Two main classes can be distinguished: steroid hormones, such as 17p-oestradiol and progesterone (for review see Rao and Slotman, 1991) and proteins such as insulin-like growth factors (IGFs), (Yee et a!., 1991), platelet-derived growth factor (PDGF), (Henriksen et al., 1993) , M-CSF (Baiocchi et al., 1991; Berchuk et al., 1992) , TNF (Naylor et al., 1993; Wu et al., 1993) , transfoming growth factor alpha (TGF-a), (Kurachi et al., 1991) , IL-I (Li et al., 1992) and IL-6 (Watson et al., 1993) .
In our case a contribution to c-myc stimulation by steriod KC hormones could be ruled out because the autocrine activity was protease sensitive. It was found that M-CSF and its receptor, the c-fins oncogene, are both expressed in N.A cells and thus this could result in a perpetual autocrine growth stimulus as sug by Malik and Balkwill (1991). 'DH Baiocchi et al., (1991) and Wiener et al., (1992) showed that a high percntage of epitheial ovarian carcinomas express M-CSF and the c-fins oncogene, and proposed that inappropriate signalling by tyrosine kinases (such as c-fins) causes growth of ovarian cancer cells, which can be r sed upon modulation of tyrosine kinase activity. 
